Skip to main content
. 2021 Sep 26;13(9):1248–1277. doi: 10.4252/wjsc.v13.i9.1248

Table 2.

Summary of the preclinical studies involving bone regeneration induced by transplantation of adipose-derived stem cells

Animal model
Scaffold used
ADSCs per implant
Time frame
Defect healing outcomes
Ref.
-Beagle Dogs; -Unilateral radial segmental defect-10 mm β-TCP/poly l-lactide-co-glycolide-co-ε-caprolactone composite scaffold 1 × 106 canine ADSCs 20 wk 33.90 ± 4.31 Kang et al[56]
-Wistar albino rats; -Middle zygomatic arch defect; -3 mm wide No scaffold Rat inguinal fat pad derived SVF 20 wk The average new bone growth in the experimental group was 1.1 mm, significantly higher than control Toplu et al[57]
Group 1: Pre-differentiated ADSCs
-New Zealand white rabbits; -Mid-diaphysis of left ulna; -20 mm long Porous polylactic glycolic acid scaffold 1 × 106 rabbit SVF cells 8 wk Approximately 55% Kim et al[58]
-Beagle dogs; -Parietal bone; -20 mm × 20 mm full-thickness defect Coral scaffold 60 × 106 of canine ADSCs 24 wk 84.19 ± 6.45 Cui et al[59]
-Lewis rats; -Calvarial defect -8 mm wide Polylactic scaffold 0.1 × 106 rat ADSCs 8 wk Coculture of endothelial- and osteoblast-induced ADSC showed no significant improvement over undifferentiated cells Shah et al[60]
-Lewis rats; -Calvarial defect; -8 mm wide Poly (D,L-Lactide) scaffold 0.1 × 106 rat ADSCs 8 wk Osteogenic-induced ADSC generated 0.91 ± 0.65 mm3 new bone, significantly higher than endothelial-induced ADSC Sahar et al[61]
Group 2: FGF, VEGF, PDGF, and ADSCs
-Osterix‐mCherry reporter mice; -Closed transverse diaphysis fractures of the right femur No scaffold 0.3 × 106 wild-type mice ADSCs 35 d The experimental group induced significantly larger mineralized surface and bone callus compared to cell-free and non-transduced controls. Zhang et al[62]
-Balb/c nude mice; -Parietal bone defect; -4 mm wide Whitlockite‐reinforced gelatin/heparin cryogels 1 × 106 human ADSCs 8 wk > 16% Kim et al[63]
-CD1 nude mice; -Parietal bone defect; -4 mm wide Coral scaffold 1.5 × 106 human ADSCs 8 wk 95.40% Behr et al[64]
-Sprague Dawley rats; -Distal femoral cancellous bone -3.5 mm wide and 5 mm deep defect Trimodal mesoporous bioactive glass scaffold 20 × 106 cell/mL until saturation; rat ADSCs 8 wk 14.25 ± 3.57 Du et al[65]
-Nu/Nu J mice; -Parietal bone; -4 mm wide Polycaprolactone - fibrin scaffold containing heparin-conjugated decellularized bone 0.2 × 106 human ADSCs 12 wk The experimental group induced a significantly larger new bone volume compared to the control without PDGF Rindone et al[66]
Group 3: BMP and ADSCs
-Sprague Dawley rats; -Full-thickness parietal bone defect -5 mm wide Polylactic glycolic acid scaffold 0.0025 × 106 human ADSCs 8 wk 33.3 ± 29.0 Park et al[67]
-Chinese white rabbits; -Full-thickness calvarial defects; -8 mm Fibrin gel matrix 3 × 106 rabbit ADSCs 12 wk Approximately 48 Lin et al[68]
-Japanese white rabbits; -Segmental radial defect; -15 mm Nano-hydroxyapatite/recombinant human-like collagen/poly (lactic acid) scaffold 2 × 106 cells/ml; rabbit ADSCs 12 wk 97.25 ± 2.06 Hao et al[69]
-Taiwan Lee-Sung minipigs; -Mid-shaft left femur defect; -30 mm long Apatite coated poly (L-lactide-co-glycolide) scaffolds 100 × 106 cells/animal; minipig ADSCs 12 wk Experimental group’s new bone formation showed equivalent density and volume compared to native bone and is significantly better than non-transduced control Lin et al[70]
-CD-1 nude mice; -Full-thickness parietal bone defect -3 mm wide Porous poly(lactic-co- glycolic acid) scaffold 3 × 106 cells/mL; ADSC from C57BL/6 mouse 6 wk 77% Fan et al[71]
-Nude mice; -Parietal bone defect; -4 mm wide Polylactic glycolic acid scaffold 5 × 105 human ADSCs 12 wk 83% Li et al[72]
-Nude mice; -Subcutaneous implantation Porous poly(lactic-co- glycolic acid) scaffold 0.01 × 106 rat ADSCs 4 wk Transduced ADSC construct induced more bone and vessel formation compared to cell-free and non-transduced control Weimin et al[73]
-CD‐1 nude mice; -Right parietal bone defect; -4 mm wide Polylactic glycolic acid scaffold 0.15 × 106 human ADSCs 6 wk Up to 100% Levi et al[74]
-Athymic nude rat; -Mandible defect; -5 × 5 mm Chitosan/chondroitin sulfate scaffold 0.25 × 106 ADSCs from C57BL/6 mouse 8 wk Approximately 43% Fan et al[75]
Group 4: Genetically manipulated ADSCs
-BALB/c nude mice; -Subcutaneous implantation β-tricalcium phosphate scaffold 2 × 106 human ADSCs 8 wk Approximately 30% Wang et al[76]
-Sprague Dawley rats; -Calvarial defect; -8 mm wide and 1 mm thick Poly (sebacoyl diglyceride) scaffold Rat ADSCs 8 wk 50.53 ± 4.45 Xie et al[77]
Group 5: Engineered scaffolds and ADSCs
-C57BL6/J mice; -Mid femur defect; -2 mm Strontium-substituted hydroxyapatite poly (γ-benzyl-l-glutamate) scaffold 5 × 106 C57BL6/J mice ADSCs 8 wk Approximately 38% Gao et al[78]
-Sprague Dawley rats; -Full-thickness femur defect; -4 mm wide NaB/polylactic glycolic acid scaffold 1 × 106 rat ADSCs 4 wk ADSC-seeded poly lactic glycolic acid scaffold with 0.05% NaB induced the highest bone density, compared to cell-free control and other concentration of NaB Doğan et al[79]
-Balb/c nude mice; -Cranium defect; -4 mm wide SiRNA lipidoid nanoparticle immobilized on polydopamine coated PLGA scaffold 1.0 × 106 human ADSCs 8 wk Approximately 75% Shin et al[80]
-Sprague Dawley rats; -Calvarial defect; -5 mm wide Collagen-resveratrol scaffold 0.05 × 106 human ADSCs 2 wk Undifferentiated ADSC-seeded construct exhibited better osteogenesis compared to controls and osteoinduced ADSC seeded scaffold Wang et al[81]
-Athymic nu/nu mice; -Subcutaneous implantation Alginate microspheres 0.5 × 106 rabbit ADSC 12 wk Approximately 41% Man et al[82]
Group 6: Manipulation of recipient host and ADSCs
-Sprague-Dawley rats; -Calvarial defect; -7 mm wide Polylactic glycolic acid scaffold 1 × 106 human ADSCs 12 wk Approximately 60% Wang et al[83]
-C57 black/DBA mice; -Supracondylar right femur defect -0.9 mm wide Hydrogel 0.3 × 106 mice ADSC 8 wk Approximately 50% Deng et al[84]
-Osteoporotic Sprague-Dawley female rats; -Distal epiphysis left femur defect; -3 mm wide Gelatin 2 × 106 rat ADSCs 5 wk Approximately 23% Li et al[85]
Group 7: Allogeneic ADSCs
-New Zealand white rabbits; -Ulna defect; -15 mm Demineralized bone matrix 60 × 106 rabbit ADSCs 12 wk Both allogeneic and autologous ADSC seeded construct induced almost complete defect repair while cell-free control remained unrepaired Gu et al[86]
-Sprague Dawley rats; -Ulna defect; -8 mm long Demineralized bone matrix 60 × 106 rat ADSCs 24 wk Radiographs and histology confirmed superior bone healing in the experimental group compared to cell-free control Wen et al[87]
-Beagle Dogs; -Parietal bone defect; -20 × 20 mm Coral scaffold 60 × 106 of canine ADSC 24 wk Approximately 70% Liu et al[88]
-Wistar rats; -Left radius defect; -4 mm long Heterogeneous deproteinized bone 0.1 × 106 rat ADSCs 8 wk Radiographs and histology confirmed improved healing in osteoinduced ADSC/scaffold group compared to undifferentiated ADSC, cell-free, and blank controls Liu et al[89]
Group 8: Non-manipulated or unaltered ADSCs
Decellularized matrices
-CD1 nude mice; -Distal femur defect -3 mm Human cancellous bone scaffold 0.5 × 106 human ADSCs 8 wk hADSCs-seeded scaffold induced significantly superior defect healing compared to cell-free scaffold Wagner et al[90]
-C57BL/6 mice; -Calvarial defect; -4 mm wide Extracellular matrix deposited on porcine small intestinal submucosa 0.0025 × 106 of human ADSCs 4 wk 21.77 ± 6.99 Zhang et al[91]
-Institute of Cancer Research mice; -Full-thickness parietal defect; -4 mm wide Decellularized tendon 1.0 × 106 human ADSCs 8 wk 86% Ko et al[92]
-Sprague Dawley rats; -Two-wall periodontal intrabony defect; -2.6 × 2.0 × 2.0 mm Amniotic membrane 0.3 × 106 human ADSCs 3 wk ADSC-seeded scaffold resulted in a significantly smaller defect size than the control Wu et al[93]
Ceramics
-Sheep; -Tibia; -3.2 cm long defect Hydroxyapatite-based particle in a semi-solid milieu 56 × 106 human ADSCs 12 wk The experimental group showed bridging and significantly better healing compared to control Ben-David et al[94]
-New Zealand White rabbits; -Full-thickness proximal medial tibia defect; -8 mm wide Hydroxyapatite 0.2 × 106 rabbit ADSCs 8 wk The new bone area was equivalent between seeded and unseeded scaffold; however, ADSC seeded construct represented preferable histological characteristics Arrigoni et al[95]
-New Zealand White rabbits; -Full-thickness proximal medial tibia; -8 mm in diameter Hydroxyapatite 1.5 × 106 rabbit ADSCs 8 wk ADSC-seeded scaffold exhibited better scaffold resorption than cell-free scaffold and superior histological characteristics compared to all controls De Girolamo et al[96]
-Fisher 344 rats; -Calvarial defect; -5 mm wide Hydroxyapatite 0.4 × 105 rat ADSCs 8 wk 16.88 ± 1.52 Xia et al[97]
-T and B cell-deficient NOD SCID mice; -Subcutaneous implantation Type I collagen (30%) and magnesium-enriched hydroxyapatite 1 × 106 human ADSCs 8 wk hADSC-seeded presented improved osteogenesis and angiogenesis compared to cell-free scaffold control Calabrese et al[98]
-Miniature Pigs; -Mandibular defect -3 cm × 1 cm × 2 cm Tri-calcium phosphate- poly (D,L-lactide-co-glycolide) scaffolds 5 × 106 porcine ADSCs 12 wk 34.8 ± 4.80 Probst et al[99]
Bioactive glass
-Wistar rats; -Full-thickness calvarial defect; -8 mm wide Bioactive glass 0.5 × 106 rat ADSCs 12 wk ADSC-seeded scaffold group exhibited significantly more bone repair and higher bone density compared to blank control. ADSC construct’s result was equivalent to that of autologous bone graft Saçak et al[100]
-Sprague Dawley rats; -Parietal bone defect; -8 mm wide Icariin doped bioactive glass 0.5 × 106 rat ADSCs 12 wk The experimental group saw the complete repair of the defect while all controls showed various degrees of incomplete healing; repair in the experimental group is characterized by mature bone and complete scaffold resorption Jing et al[101]
Polymers
-Wistar rats; -Calvarial defect; -5 mm wide Polycaprolactone scaffold 0.05 × 106 human ADSCs 8 wk Both undifferentiated and osteo-induced ADSC-seeded scaffold resulted in preferable histological features and higher expression of osteogenesis and angiogenesis markers Caetano et al[102]
Platelet-rich plasma as carrier material
-Beagle dogs; -Tibial defects; -10 mm wide Activated platelet-rich plasma 1.0 × 106 human ADSCs 6 wk 68.97 ± 0.91 Cruz et al[103]
-F344 rat; -Calvarial defect; -5 mm wide Activated platelet-rich plasma 0.2 × 106 rat ADSCs 8 wk 95.60 Tajima et al[104]
Hybrid materials
-New Zealand white rabbits; -Calvarial defect; -10 mm wide Hyaluronic acid-g-chitosan-g-poly (N-isopropylacrylamide) embedded with biphasic calcium phosphate microparticles and PRP 0.1 × 106 rabbit ADSCs 16 wk The experimental group induced obvious significant bone formation and defect bridging. Cell-free scaffold control showed negligible defect repair Liao et al[105]
-Sprague Dawley rats; -Parietal defect; -5 mm wide Multi-layered stacking of electrospun polycaprolactone/gelatin membranes 0.006 × 106 rat ADSCs 12 wk Up to 90% Wan et al[106]
-Balb/c nude mice; -Calvarial defect; -4 mm wide 1H,1H,2H,2H-per- fluorodecyl acrylate (97%) and glycidyl methacrylate coated paper scaffold 1.0 × 106 cells/paper human ADSCs 8 wk 92% Park et al[107]

ADSCs: Adipose-derived stem cells; SVF: Stromal Vascular Fraction; PRP: Platelet-rich plasma.